Document is current

Article History

Received: 20 August 2024

Accepted: 19 November 2024

First Online: 30 November 2024

Declarations

:

: The MOSA study was approved by the Mondriaan Mental Health Care Institutional Review Board (IRB no. CWO21017) and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice. Prior to their participation in the study, patients were informed orally and in writing, and provided written informed consent. Similarly, the treating clinicians were informed and required to provide consent to participate with their respective patients.Patients were invited to participate in the study on an entirely voluntary basis and were at liberty to cease taking the weight-loss medication or withdraw from the study at any time. The decision to utilise a pharmacological intervention was made by the clinician and the patient as part of regular clinical care. The confidentiality of the participants was guaranteed, and no personally identifying information was utilised. All data were rendered anonymous through the application of pseudonyms.

: NA.

: The authors declare no competing interests.